Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

NCT00003622 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No recruitment

Conditions

Prostate Cancer

Interventions

DRUG: paclitaxel
DRUG: vinorelbine tartrate

Sponsor

James Ahlgren